Feeds
112833 items (87119 unread) in 107 feeds
- Dictionary.com Word of the Day (108 unread)
- Yahoo! News: Most Viewed (2476 unread)
The Economic Times - Healthcare / Biotech (10 unread)
-
Quality marks for generic drugs may be must soon
Fetched: October 10th, 2008, 10:42pm EDT
The government and the industry are in talks to introduce quality marks for these medicines to ensure consumers don’t buy sub-standard drugs. -
Aurobindo Pharma gets USFDA nod for two drugs
Fetched: October 10th, 2008, 10:42pm EDT
Aurobindo Pharma on Friday said it has received approval from the US drug regulator for manufacturing and marketing two drugs - Cyclobenzaprine Hydrochloride and Fluconazole Tablets - in that country. -
Wockhardt in licensing pact with UK firm
Fetched: October 10th, 2008, 10:42pm EDT
Drug firm Wockhardt Ltd said on Friday it has signed an in-licensing deal with Sinclair Pharma Plc of UK to market a range of dermatology and dental products. -
Drug regulators must act in concert
Fetched: October 9th, 2008, 10:58pm EDT
Lack of regulatory foresight, coordination & policy lacunae are creating problems for pharma cos. -
US justice dept withdraws motion against Ranbaxy
Fetched: October 8th, 2008, 9:16pm EDT
The US Department of Justice (DoJ) has withdrawn its motion in a local court against Ranbaxy after the Indian drug maker handed over the documents sought by the authorities. -
Dr Reddy’s eyes new ops for Perlecan candidates
Fetched: October 8th, 2008, 9:16pm EDT
Drug-maker Dr Reddy’s Laboratories will stop innovative drug research at Perlecan Pharma, its wholly-owned subsidiary, due to a virtual freeze on R&D spends. -
Input costs, short supplies hit bulk drug makers hard
Fetched: October 8th, 2008, 9:16pm EDT
Rising input costs and short supplies have hit the fortunes of the domestic active pharmaceutical ingredient (API) industry, especially in the last quarter. -
Ranbaxy upbeat as US Dept of Justice withdraws motion
Fetched: October 8th, 2008, 9:38am EDT
Pharmaceutical major Ranbaxy Labortaories today said it remained confident that its products were safe and effective as the US Department of Justice (DoJ) withdrew a legal motion against it that charged fraudlent practice. -
Pharmaceutical firm to invest USD 300 mn in Malaysia
Fetched: October 8th, 2008, 9:38am EDT
Malladi Drugs and Pharmaceutical Ltd will invest up to USD 300 million over the next three to five years to set up its global "one-stop shop" in Malaysia. -
Dr Reddy's gets US nod for primidone
Fetched: October 8th, 2008, 9:38am EDT
Dr Reddy's Laboratories Ltd has received approval from the US Food and Drug Administration to sell its anti-convulsant drug primidone.